Gene Therapy Solutions
Amwins Benefits partners with brokers to help their clients navigate the future of gene therapy through smart, practical, and comprehensive risk-management programs and strategies. We deliver unrivaled knowledge and expertise to our retail partners,
providing meaningful solutions that protect employers as they face the ever evolving and complex gene therapy landscape.
Gene Therapy Solutions
Amwins Benefits partners with brokers to help their clients navigate the future of gene therapy through smart, practical, and comprehensive risk-management programs and strategies. We deliver unrivaled knowledge and expertise to our retail partners,
providing meaningful solutions that protect employers as they face the ever evolving and complex gene therapy landscape.
Understanding the Gene
Therapy Landscape
The Growing Market
According to the FDA, there are currently more than 50+ cellular and gene therapies available in the market today, with seven to 10 additional treatments predicted for approval within the next year.
Current treatment costs range from $400,000 to $4,250,000 per patient, and these costs are expected to continue rising as additional gene therapy treatments receive market approval.
Amwins Gene Therapy Solutions: Program Advantages
When coupled with stop-loss coverage, this cost-containment program provides a sustainable strategy that prepares employers to face unexpected, high-dollar gene therapy claims with confidence.
